These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 33914067)

  • 1. Targeting the CSF1/CSF1R axis is a potential treatment strategy for malignant meningiomas.
    Yeung J; Yaghoobi V; Miyagishima D; Vesely MD; Zhang T; Badri T; Nassar A; Han X; Sanmamed MF; Youngblood M; Peyre M; Kalamarides M; Rimm DL; Gunel M; Chen L
    Neuro Oncol; 2021 Nov; 23(11):1922-1935. PubMed ID: 33914067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade.
    Zhu Y; Yang J; Xu D; Gao XM; Zhang Z; Hsu JL; Li CW; Lim SO; Sheng YY; Zhang Y; Li JH; Luo Q; Zheng Y; Zhao Y; Lu L; Jia HL; Hung MC; Dong QZ; Qin LX
    Gut; 2019 Sep; 68(9):1653-1666. PubMed ID: 30902885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy.
    Cannarile MA; Weisser M; Jacob W; Jegg AM; Ries CH; Rüttinger D
    J Immunother Cancer; 2017 Jul; 5(1):53. PubMed ID: 28716061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CSF1/CSF1R-mediated Crosstalk Between Choroidal Vascular Endothelial Cells and Macrophages Promotes Choroidal Neovascularization.
    Zhou Y; Zeng J; Tu Y; Li L; Du S; Zhu L; Cang X; Lu J; Zhu M; Liu X
    Invest Ophthalmol Vis Sci; 2021 Mar; 62(3):37. PubMed ID: 33764399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic Ductal Adenocarcinoma (PDAC) circulating tumor cells influence myeloid cell differentiation to support their survival and immunoresistance in portal vein circulation.
    Arnoletti JP; Reza J; Rosales A; Monreal A; Fanaian N; Whisner S; Srivastava M; Rivera-Otero J; Yu G; Phanstiel Iv O; Altomare DA; Tran Q; Litherland SA
    PLoS One; 2022; 17(3):e0265725. PubMed ID: 35316296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF1/CSF1R signaling mediates malignant pleural effusion formation.
    Kosti CN; Vaitsi PC; Pappas AG; Iliopoulou MP; Psarra KK; Magkouta SF; Kalomenidis IT
    JCI Insight; 2022 Mar; 7(6):. PubMed ID: 35315360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment.
    Fujiwara T; Yakoub MA; Chandler A; Christ AB; Yang G; Ouerfelli O; Rajasekhar VK; Yoshida A; Kondo H; Hata T; Tazawa H; Dogan Y; Moore MAS; Fujiwara T; Ozaki T; Purdue E; Healey JH
    Mol Cancer Ther; 2021 Aug; 20(8):1388-1399. PubMed ID: 34088832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-1β-Induced Elevation of Solute Carrier Family 7 Member 11 Promotes Hepatocellular Carcinoma Metastasis Through Up-regulating Programmed Death Ligand 1 and Colony-Stimulating Factor 1.
    He Q; Liu M; Huang W; Chen X; Zhang B; Zhang T; Wang Y; Liu D; Xie M; Ji X; Sun M; Tian D; Xia L
    Hepatology; 2021 Dec; 74(6):3174-3193. PubMed ID: 34288020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSF1/CSF1R Axis Blockade Limits Mesothelioma and Enhances Efficiency of Anti-PDL1 Immunotherapy.
    Magkouta SF; Vaitsi PC; Pappas AG; Iliopoulou M; Kosti CN; Psarra K; Kalomenidis IT
    Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34067348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S-nitrosylation of CSF1 receptor increases the efficacy of CSF1R blockage against prostate cancer.
    Firdaus F; Kuchakulla M; Qureshi R; Dulce RA; Soni Y; Van Booven DJ; Shah K; Masterson T; Rosete OJ; Punnen S; Hare JM; Ramasamy R; Arora H
    Cell Death Dis; 2022 Oct; 13(10):859. PubMed ID: 36209194
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Hawley CA; Rojo R; Raper A; Sauter KA; Lisowski ZM; Grabert K; Bain CC; Davis GM; Louwe PA; Ostrowski MC; Hume DA; Pridans C; Jenkins SJ
    J Immunol; 2018 Mar; 200(6):2209-2223. PubMed ID: 29440354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colony-stimulating factor-1 and colony-stimulating factor-1 receptor co-expression is associated with disease progression in gastric cancer.
    Okugawa Y; Toiyama Y; Ichikawa T; Kawamura M; Yasuda H; Fujikawa H; Saigusa S; Ohi M; Araki T; Tanaka K; Inoue Y; Tanaka M; Miki C; Kusunoki M
    Int J Oncol; 2018 Aug; 53(2):737-749. PubMed ID: 29767252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of tumor-derived colony-stimulating factor 1 (CSF1) promotes an immune-permissive tumor microenvironment.
    Maldonado MDM; Schlom J; Hamilton DH
    Cancer Immunol Immunother; 2023 Oct; 72(10):3349-3362. PubMed ID: 37505292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production and characterisation of a monoclonal antibody that recognises the chicken CSF1 receptor and confirms that expression is restricted to macrophage-lineage cells.
    Garcia-Morales C; Rothwell L; Moffat L; Garceau V; Balic A; Sang HM; Kaiser P; Hume DA
    Dev Comp Immunol; 2014 Feb; 42(2):278-85. PubMed ID: 24084378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defects in Macrophage Reprogramming in Cancer Therapy: The Negative Impact of PD-L1/PD-1.
    Cai H; Zhang Y; Wang J; Gu J
    Front Immunol; 2021; 12():690869. PubMed ID: 34248982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colony-Stimulating Factor 1 Receptor (CSF1R) Activates AKT/mTOR Signaling and Promotes T-Cell Lymphoma Viability.
    Murga-Zamalloa C; Rolland DCM; Polk A; Wolfe A; Dewar H; Chowdhury P; Onder O; Dewar R; Brown NA; Bailey NG; Inamdar K; Lim MS; Elenitoba-Johnson KSJ; Wilcox RA
    Clin Cancer Res; 2020 Feb; 26(3):690-703. PubMed ID: 31636099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational combination of an immune checkpoint inhibitor with CSF1R inhibitor-loaded nanoparticle enhances anticancer efficacy.
    Ramesh A; Malik V; Ranjani HA; Smith H; Kulkarni AA
    Drug Deliv Transl Res; 2021 Dec; 11(6):2317-2327. PubMed ID: 34365577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting CSF1R in myeloid-derived suppressor cells: insights into its immunomodulatory functions in colorectal cancer and therapeutic implications.
    Tong X; Qiao S; Dong Z; Zhao X; Du X; Niu W
    J Nanobiotechnology; 2024 Jul; 22(1):409. PubMed ID: 38992688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rh-CSF1 attenuates neuroinflammation via the CSF1R/PLCG2/PKCε pathway in a rat model of neonatal HIE.
    Hu X; Li S; Doycheva DM; Huang L; Lenahan C; Liu R; Huang J; Xie S; Tang J; Zuo G; Zhang JH
    J Neuroinflammation; 2020 Jun; 17(1):182. PubMed ID: 32522286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rh-CSF1 Attenuates Oxidative Stress and Neuronal Apoptosis via the CSF1R/PLCG2/PKA/UCP2 Signaling Pathway in a Rat Model of Neonatal HIE.
    Hu X; Li S; Doycheva DM; Huang L; Lenahan C; Liu R; Huang J; Gao L; Tang J; Zuo G; Zhang JH
    Oxid Med Cell Longev; 2020; 2020():6801587. PubMed ID: 33101590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.